Sandy Hook, CT, United States of America

Revati J Tatake

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim International Gmbh. Active years: 2003-2010.

USPTO Granted Patents = 4 (Patent Applications = 1)

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 18(Granted Patents)

Company Filing History:

3 out of 278

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

1 out of 1,560

Boehringer Ingelheim International Gmbh

patents

Years Active: 2003-2010

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7829664 - Modified nucleotide sequence encoding glucagon-like peptide-1 (GLP-1), nucleic acid construct comprising same for production of glucagon-like peptide-1 (GLP-1), human cells comprising said construct and insulin-producing constructs, and methods of use thereof (2010-11-09),

2. 7045346 - Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines (2006-05-16),

3. 6537784 - Self-regulated apoptosis of inflammatory cells by gene therapy (2003-03-25),

4. 6525184 - Self-regulated apoptosis of inflammatory cells (2003-02-25),

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]

1 patent pending:

Please report any incorrect information to [email protected]

1 patent pending (CIPO):

Please report any incorrect information to [email protected]

1 patent pending (EPO):

Please report any incorrect information to [email protected]